<DOC>
	<DOCNO>NCT00760747</DOCNO>
	<brief_summary>Children adolescent Attention Deficit Hyperactivity Disorder ( ADHD ) tolerate respond well stimulant therapy include study . Two different strategy transition Stimulant Atomoxetine use : Slow ( 10 week ) fast ( 2 week ) . Changes ADHD symptom tolerability medication compare two different switch approach .</brief_summary>
	<brief_title>Comparison Slow Fast Transition From Stimulants Atomoxetine Children Adolescents With Attention Deficit/Hyperactivity Disorder ( ADHD )</brief_title>
	<detailed_description>Study B4Z-EW-LYFJ phase IV multicentre , open label , control study approximately 120 patient ADHD 6 year 16 year age . After screen period , patient randomize ( centrally 1:1 ratio ) either transition period 10 week ( slow switching arm ) transition period 2 week ( fast switching arm ) . After completion 10 week open phase patient treat 4 week atomoxetine .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Atomoxetine Hydrochloride</mesh_term>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<criteria>Outpatients 616 year age Diagnostic Statistical Manual Mental Disorders Fourth Edition ( DSMIV ) diagnostic criterion ADHD must meet Normal laboratory electrocardiogram ( ECG ) result Normal intelligence Must unsatisfactory symptom response stimulant therapy experience adverse event stimulant therapy Less 20 kg 70 kg study entry Concomitant major psychiatry disorder , drug alcohol abuse serious suicide risk Medical condition seizure , severe allergy , glaucoma , cardiovascular disease , hypertension , acute unstable medical condition Taking anticonvulsant , antihypertensive agent , medication sympathomimetic activity , psychotropic medication , monoamine oxidase inhibitor Immediate need stimulant discontinuation due tolerability problem Previous participation atomoxetine study , unresponsive atomoxetine , intolerable side effect atomoxetine</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>16 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>ADHD</keyword>
	<keyword>Children</keyword>
	<keyword>Stimulant</keyword>
	<keyword>Atomoxetine</keyword>
	<keyword>Adolescents</keyword>
</DOC>